These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35126995)

  • 21. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
    Kaplan AP; Giménez-Arnau AM; Saini SS
    Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria.
    Rauber MM; Pickert J; Holiangu L; Möbs C; Pfützner W
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2078-2085. PubMed ID: 31954076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantity increase and functional affinity/avidity decrease of anti-FcεRI and anti-IgE autoantibodies in chronic spontaneous urticaria.
    Joerg L; Mueller-Wirth N; Kammermann K; Stalder O; Pichler W; Hausmann O
    Eur Ann Allergy Clin Immunol; 2024 Nov; 56(6):271-280. PubMed ID: 38088172
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.
    ; Yu R; Qian W; Zheng Q; Xiong J; Chen S; Chen A; Chen J; Fang S; Huang K; Cai T
    Int Arch Allergy Immunol; 2023; 184(7):643-655. PubMed ID: 36996780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparable actions of omalizumab on mast cells and basophils.
    Serrano-Candelas E; Martinez-Aranguren R; Valero A; Bartra J; Gastaminza G; Goikoetxea MJ; Martín M; Ferrer M
    Clin Exp Allergy; 2016 Jan; 46(1):92-102. PubMed ID: 26509363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.
    Oliver JM; Tarleton CA; Gilmartin L; Archibeque T; Qualls CR; Diehl L; Wilson BS; Schuyler M
    Int Arch Allergy Immunol; 2010; 151(4):275-84. PubMed ID: 19844128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of omalizumab on basophils: Potential biomarkers in asthma and chronic spontaneous urticaria.
    Poddighe D; Vangelista L
    Cell Immunol; 2020 Dec; 358():104215. PubMed ID: 33137647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Potential Role of Basophils in Urticaria.
    Takimoto-Ito R; Ma N; Kishimoto I; Kabashima K; Kambe N
    Front Immunol; 2022; 13():883692. PubMed ID: 35663949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab.
    Maronese CA; Ferrucci SM; Moltrasio C; Lorini M; Carbonelli V; Asero R; Marzano AV; Cugno M
    J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615181
    [No Abstract]   [Full Text] [Related]  

  • 30. Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response.
    Gimeno R; Ribas-Llauradó C; Pesque D; Andrades E; Cenni B; Ambros B; Pujol R; Giménez-Arnau AM
    Clin Transl Allergy; 2023 Mar; 13(3):e12227. PubMed ID: 36973953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated, FcεRI-dependent MRGPRX2 expression on basophils in chronic urticaria.
    Bartko EA; Elberling J; Blom LH; Poulsen LK; Jensen BM
    Skin Health Dis; 2023 Jun; 3(3):e195. PubMed ID: 37275407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
    Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
    J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
    Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
    Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management problems in severe chronic inducible urticaria: Two case reports.
    Bumbăcea RS; Deaconu CG; Berghea EC
    Exp Ther Med; 2019 Aug; 18(2):960-963. PubMed ID: 31384330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and FcεRI.
    Iwamoto T; Hirai H; Yamaguchi N; Kobayashi N; Sugimoto H; Tabata T; Okuda M
    Cancer Sci; 2014 Nov; 105(11):1472-9. PubMed ID: 25230301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unveiling Treatment Response Predictors in Predominant Subtypes of Chronic Inducible Urticaria.
    Ornek Ozdemir S; Can PK; Degirmentepe EN; Kızıltaç K; Singer R; Kocatürk E
    Int Arch Allergy Immunol; 2024; 185(11):1055-1065. PubMed ID: 38889696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD300c costimulates IgE-mediated basophil activation, and its expression is increased in patients with cow's milk allergy.
    Zenarruzabeitia O; Vitallé J; Terrén I; Orrantia A; Astigarraga I; Dopazo L; Gonzalez C; Santos-Díez L; Tutau C; Gamboa PM; Bilbao A; Borrego F
    J Allergy Clin Immunol; 2019 Feb; 143(2):700-711.e5. PubMed ID: 29906528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
    Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
    Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.